chtnt-1

mAbexperimental

Clinical trial activity

5 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2000 (NCT00004017)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Payload
131-iodine

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 131i-chimeric tnt-1-b monoclonal antibody
  • 131i-chtnt-1/b
  • 131-i-chtnt-1/b mab
  • 131i-chtnt-1-b mab
  • 131i-chtnt-1-b monoclonal antibody
  • chtnt-1
  • chtnt-1 131i
  • cotara
  • cotara
  • cotara
  • tnt-1b
  • tnt-1/b

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02724267N/ANov 1, 2012Eastern Hepatobiliary Surgery Hospital
NCT00677716Phase 2Jul 1, 2007All India Institute of Medical Sciences, Avid Bioservices
NCT00509301Phase 1Nov 1, 2006Avid Bioservices, Barrow Neurological Institute, Case Western Reserve University, Medical University of South Carolina, University of Pennsylvania
NCT00128635Phase 1Oct 1, 2005National Cancer Institute (NCI), University of Pennsylvania
NCT00004017Phase 2Feb 1, 2000Avid Bioservices
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Avid BioservicesFor profit3322000
University of PennsylvaniaAcademic/Hospital2112005
All India Institute of Medical SciencesAcademic/Hospital1012007
Barrow Neurological InstituteAcademic/Hospital1012006
Case Western Reserve UniversityAcademic/Hospital1012006
Eastern Hepatobiliary Surgery HospitalAcademic/Hospital1112012
Medical University of South CarolinaAcademic/Hospital1012006
National Cancer Institute (NCI)Government1012005
8 organizations
Page 1 / 1